位置:首页 > 蛋白库 > KI3S1_HUMAN
KI3S1_HUMAN
ID   KI3S1_HUMAN             Reviewed;         382 AA.
AC   Q14943; A0A0G2JNN4; Q5UCD2;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   27-SEP-2017, sequence version 2.
DT   25-MAY-2022, entry version 172.
DE   RecName: Full=Killer cell immunoglobulin-like receptor 3DS1 {ECO:0000305};
DE   AltName: Full=Natural killer-associated transcript 10;
DE            Short=NKAT-10;
DE   Flags: Precursor;
GN   Name=KIR3DS1 {ECO:0000312|HGNC:HGNC:6340}; Synonyms=NKAT10;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE 3DS1*010).
RX   PubMed=8662091; DOI=10.1007/bf02602590;
RA   Doehring C., Samaridis J., Colonna M.;
RT   "Alternatively spliced forms of human killer inhibitory receptors.";
RL   Immunogenetics 44:227-230(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE KIR3DS1*014).
RA   Norman P.J., Pando M., Yawata N., Yawata M., Tyan D., Parham P.;
RT   "Diversity of KIR3DL1. i. allele confirmation; genomic DNA from individuals
RT   other than original donor.";
RL   Submitted (SEP-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE KIR3DS1*014).
RX   PubMed=23394822; DOI=10.1186/1471-2164-14-89;
RA   Pyo C.W., Wang R., Vu Q., Cereb N., Yang S.Y., Duh F.M., Wolinsky S.,
RA   Martin M.P., Carrington M., Geraghty D.E.;
RT   "Recombinant structures expand and contract inter and intragenic
RT   diversification at the KIR locus.";
RL   BMC Genomics 14:89-89(2013).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ALLELE KIR3DS1*055).
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [5]
RP   FUNCTION, SUBUNIT, AND INTERACTION WITH HLA-F.
RX   PubMed=27455421; DOI=10.1038/ni.3513;
RA   Garcia-Beltran W.F., Hoelzemer A., Martrus G., Chung A.W., Pacheco Y.,
RA   Simoneau C.R., Rucevic M., Lamothe-Molina P.A., Pertel T., Kim T.E.,
RA   Dugan H., Alter G., Dechanet-Merville J., Jost S., Carrington M.,
RA   Altfeld M.;
RT   "Open conformers of HLA-F are high-affinity ligands of the activating NK-
RT   cell receptor KIR3DS1.";
RL   Nat. Immunol. 17:1067-1074(2016).
RN   [6]
RP   SUBUNIT, AND INTERACTION WITH HLA-F.
RX   PubMed=28636952; DOI=10.1016/j.immuni.2017.06.002;
RA   Dulberger C.L., McMurtrey C.P., Holzemer A., Neu K.E., Liu V.,
RA   Steinbach A.M., Garcia-Beltran W.F., Sulak M., Jabri B., Lynch V.J.,
RA   Altfeld M., Hildebrand W.H., Adams E.J.;
RT   "Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through
RT   Interactions with NK Cell Receptors.";
RL   Immunity 46:1018-1029(2017).
RN   [7]
RP   POLYMORPHISM.
RX   PubMed=10781084; DOI=10.1073/pnas.080588597;
RA   Wilson M.J., Torkar M., Haude A., Milne S., Jones T., Sheer D., Beck S.,
RA   Trowsdale J.;
RT   "Plasticity in the organization and sequences of human KIR/ILT gene
RT   families.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:4778-4783(2000).
RN   [8]
RP   POLYMORPHISM.
RX   PubMed=11513141; DOI=10.1034/j.1600-065x.2001.1810102.x;
RA   Trowsdale J., Barten R., Haude A., Stewart C.A., Beck S., Wilson M.J.;
RT   "The genomic context of natural killer receptor extended gene families.";
RL   Immunol. Rev. 181:20-38(2001).
RN   [9]
RP   VARIANT HIS-166.
RX   PubMed=9430221; DOI=10.1016/s1074-7613(00)80394-5;
RA   Uhrberg M., Valiante N.M., Shum B.P., Shilling H.G., Lienert-Weidenbach K.,
RA   Corliss B., Tyan D., Lanier L.L., Parham P.;
RT   "Human diversity in killer cell inhibitory receptor genes.";
RL   Immunity 7:753-763(1997).
CC   -!- FUNCTION: Receptor on natural killer (NK) cells for MHC class I
CC       molecules. Upon interaction with peptide-free HLA-F open conformer,
CC       triggers NK cell degranulation and anti-viral cytokine production.
CC       {ECO:0000269|PubMed:27455421}.
CC   -!- SUBUNIT: Interacts with HLA-F open conformer; this interaction is
CC       direct. {ECO:0000269|PubMed:27455421, ECO:0000269|PubMed:28636952}.
CC   -!- INTERACTION:
CC       Q14943; Q5SUL5: HLA-A; NbExp=2; IntAct=EBI-15316524, EBI-8561769;
CC       Q14943; P01889: HLA-B; NbExp=6; IntAct=EBI-15316524, EBI-1046513;
CC       Q14943; P10321: HLA-C; NbExp=2; IntAct=EBI-15316524, EBI-1051396;
CC       Q14943; P30511: HLA-F; NbExp=6; IntAct=EBI-15316524, EBI-2811134;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein.
CC   -!- TISSUE SPECIFICITY: Expressed in NK and T-cell lines but not in B-
CC       lymphoblastoid cell lines or in a colon carcinoma cell line.
CC   -!- POLYMORPHISM: The KIR genes are located in a segment of DNA on 19q13.4
CC       in the leukocyte receptor complex that has undergone expansion and
CC       contraction over time, probably through unequal crossing-over. Thus,
CC       KIR haplotypes vary in the number and types of genes, although a few
CC       framework loci, such as the gene KIR3DL1, are present on all or nearly
CC       all haplotypes. KIR3DL1 and KIR3DS1 segregate as alleles of the locus
CC       KIR3DL1/3DS1. {ECO:0000269|PubMed:10781084,
CC       ECO:0000269|PubMed:11513141}.
CC   -!- SIMILARITY: Belongs to the immunoglobulin superfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L76661; AAB36589.1; -; mRNA.
DR   EMBL; AY760033; AAV32446.1; -; Genomic_DNA.
DR   EMBL; JX008031; AFV74772.1; -; Genomic_DNA.
DR   EMBL; CU459006; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001077008.1; NM_001083539.2.
DR   RefSeq; NP_001269099.1; NM_001282170.1.
DR   RefSeq; NP_001269100.1; NM_001282171.1.
DR   RefSeq; XP_016885749.1; XM_017030260.1.
DR   AlphaFoldDB; Q14943; -.
DR   SMR; Q14943; -.
DR   BioGRID; 306831; 26.
DR   IntAct; Q14943; 30.
DR   GlyGen; Q14943; 3 sites.
DR   iPTMnet; Q14943; -.
DR   PhosphoSitePlus; Q14943; -.
DR   BioMuta; KIR3DS1; -.
DR   DMDM; 2833258; -.
DR   jPOST; Q14943; -.
DR   MassIVE; Q14943; -.
DR   PeptideAtlas; Q14943; -.
DR   PRIDE; Q14943; -.
DR   ProteomicsDB; 60253; -.
DR   DNASU; 3813; -.
DR   Ensembl; ENST00000614217.4; ENSP00000481772.1; ENSG00000275434.5.
DR   GeneID; 3813; -.
DR   KEGG; hsa:3813; -.
DR   UCSC; uc061dvg.1; human.
DR   CTD; 3813; -.
DR   DisGeNET; 3813; -.
DR   GeneCards; KIR3DS1; -.
DR   HGNC; HGNC:6340; KIR3DS1.
DR   MIM; 604946; gene.
DR   neXtProt; NX_Q14943; -.
DR   OpenTargets; ENSG00000275434; -.
DR   InParanoid; Q14943; -.
DR   OrthoDB; 466470at2759; -.
DR   PhylomeDB; Q14943; -.
DR   PathwayCommons; Q14943; -.
DR   Reactome; R-HSA-2172127; DAP12 interactions.
DR   SignaLink; Q14943; -.
DR   BioGRID-ORCS; 3813; 0 hits in 36 CRISPR screens.
DR   GenomeRNAi; 3813; -.
DR   Pharos; Q14943; Tdark.
DR   PRO; PR:Q14943; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q14943; protein.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB.
DR   GO; GO:0006955; P:immune response; NAS:UniProtKB.
DR   GO; GO:0030101; P:natural killer cell activation; NAS:UniProtKB.
DR   Gene3D; 2.60.40.10; -; 3.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR013151; Immunoglobulin.
DR   Pfam; PF00047; ig; 3.
DR   SMART; SM00409; IG; 3.
DR   SUPFAM; SSF48726; SSF48726; 3.
PE   1: Evidence at protein level;
KW   Cell membrane; Disulfide bond; Glycoprotein; Immunoglobulin domain;
KW   Membrane; Receptor; Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000250"
FT   CHAIN           22..382
FT                   /note="Killer cell immunoglobulin-like receptor 3DS1"
FT                   /id="PRO_0000015092"
FT   TOPO_DOM        22..340
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        341..360
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        361..382
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          42..102
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          137..202
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          237..300
FT                   /note="Ig-like C2-type 3"
FT   CARBOHYD        92
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        179
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        273
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        49..95
FT                   /evidence="ECO:0000250"
FT   DISULFID        144..195
FT                   /evidence="ECO:0000250"
FT   DISULFID        244..293
FT                   /evidence="ECO:0000250"
FT   VARIANT         2
FT                   /note="L -> S (in allele KIR3DS1*010; dbSNP:rs605219)"
FT                   /id="VAR_056093"
FT   VARIANT         13
FT                   /note="L -> F (in allele KIR3DS1*014; dbSNP:rs1142881)"
FT                   /id="VAR_078992"
FT   VARIANT         68
FT                   /note="V -> I (in dbSNP:rs643347)"
FT                   /id="VAR_056094"
FT   VARIANT         157..159
FT                   /note="REW -> KEG (in allele KIR3DS1*014)"
FT                   /id="VAR_078993"
FT   VARIANT         157
FT                   /note="R -> K (in allele KIR3DS1*010)"
FT                   /id="VAR_078994"
FT   VARIANT         166
FT                   /note="R -> H (in dbSNP:rs375468097)"
FT                   /evidence="ECO:0000269|PubMed:9430221"
FT                   /id="VAR_010377"
FT   VARIANT         203
FT                   /note="P -> S (in dbSNP:rs2273731)"
FT                   /id="VAR_056095"
FT   VARIANT         220
FT                   /note="L -> P (in dbSNP:rs680891)"
FT                   /id="VAR_056096"
FT   VARIANT         259
FT                   /note="G -> R (in dbSNP:rs1049215)"
FT                   /id="VAR_056097"
FT   VARIANT         369..382
FT                   /note="KCCCNGPRACREQK -> NAAVMDQEPAGNRSEQRGF (in allele
FT                   KIR3DS1*010)"
FT                   /id="VAR_078995"
SQ   SEQUENCE   382 AA;  42475 MW;  C6897933BCEA2EE0 CRC64;
     MLLMVVSMAC VGLFLVQRAG PHMGGQDKPF LSAWPSAVVP RGGHVTLRCH YRHRFNNFML
     YKEDRIHVPI FHGRIFQEGF NMSPVTTAHA GNYTCRGSHP HSPTGWSAPS NPMVIMVTGN
     HRKPSLLAHP GPLVKSGERV ILQCWSDIMF EHFFLHREWI SKDPSRLVGQ IHDGVSKANF
     SIGSMMRALA GTYRCYGSVT HTPYQLSAPS DPLDIVVTGL YEKPSLSAQP GPKVQAGESV
     TLSCSSRSSY DMYHLSREGG AHERRLPAVR KVNRTFQADF PLGPATHGGT YRCFGSFRHS
     PYEWSDPSDP LLVSVTGNPS SSWPSPTEPS SKSGNLRHLH ILIGTSVVKI PFTILLFFLL
     HRWCSNKKKC CCNGPRACRE QK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024